NFE2L3 and breast cancer: In contrast to pancreatic and colorectal cancer, NRF3 appears to be downregulated in breast cancer compared to adjacent nonneoplastic breast and have an inhibitory effect on malignant behaviour in breast cancer in vitro [10].